The genetics of hereditary colon cancer.

The genetic basis of sporadic colorectal cancer has illuminated our knowledge of human cancer genetics. This has been facilitated and catalyzed by an appreciation and deep understanding of the forms of colorectal cancer that harbor an inherited predisposition, including familial adenomatous polyposis (FAP), hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome, the hamartomatous polyposis syndromes, and certain other rare syndromes. Identification of germline mutations in pivotal genes underlying the inherited forms of colorectal cancer has yielded many dividends, including functional dissection of critical molecular pathways that have been revealed to be important in development, cellular homeostasis, and cancer; new approaches in chemoprevention, molecular diagnostics and genetic testing, and therapy; and underscoring genotypic-phenotypic relationships.

[1]  L. Aaltonen,et al.  Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. , 2005, JAMA.

[2]  M. Radman,et al.  HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions , 1999, Nature Genetics.

[3]  Rozemary Karamatic,et al.  High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. , 2006, Gastroenterology.

[4]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[5]  R. Elston,et al.  A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Edelmann,et al.  Loss of DNA mismatch repair function and cancer predisposition in the mouse: Animal models for human hereditary nonpolyposis colorectal cancer , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.

[7]  A. Sandberg,et al.  Gardner syndrome in a man with an interstitial deletion of 5q. , 1986, American journal of medical genetics.

[8]  J. Mecklin,et al.  Hereditary non-polyposis colorectal cancer , 1991, The Lancet.

[9]  G. Petersen,et al.  AGA technical review on hereditary colorectal cancer and genetic testing. , 2001, Gastroenterology.

[10]  R. Kucherlapati,et al.  Mutation in the Mismatch Repair Gene Msh6 Causes Cancer Susceptibility , 1997, Cell.

[11]  M. Southey,et al.  An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. , 2003, American journal of human genetics.

[12]  Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. , 1988, The New England journal of medicine.

[13]  M. Stratton,et al.  A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.

[14]  Victor E. Velculescu,et al.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis , 2001, Nature Genetics.

[15]  K. Heinimann,et al.  Exclusion of an extracolonic disease modifier locus on chromosome 1p33–36 in a large Swiss familial adenomatous polyposis kindred , 2004, European Journal of Human Genetics.

[16]  M. Andreu,et al.  Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. , 2005, JAMA.

[17]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[18]  G. Thomas,et al.  Alleles of the APC gene: An attenuated form of familial polyposis , 1993, Cell.

[19]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[20]  Ossama Tawfik,et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β-catenin signaling , 2004, Nature Genetics.

[21]  Kathleen R. Cho,et al.  Activation of AXIN2 Expression by β-Catenin-T Cell Factor , 2002, The Journal of Biological Chemistry.

[22]  John D Potter,et al.  Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. , 2007, Gastroenterology.

[23]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[24]  J. Garber,et al.  Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. , 2000, JAMA.

[25]  Inke Näthke,et al.  Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC , 2006, Nature Reviews Cancer.

[26]  T. Mak,et al.  Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. , 1996, Cancer research.

[27]  H. Griesser,et al.  MSH2 deficient mice are viable and susceptible to lymphoid tumours , 1995, Nature Genetics.

[28]  G. Sapkota,et al.  Phosphorylation of the Protein Kinase Mutated in Peutz-Jeghers Cancer Syndrome, LKB1/STK11, at Ser431 by p90RSK and cAMP-dependent Protein Kinase, but Not Its Farnesylation at Cys433, Is Essential for LKB1 to Suppress Cell Growth* , 2001, The Journal of Biological Chemistry.

[29]  C. Eng,et al.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.

[30]  P. Cheah,et al.  Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function , 2005, Journal of Medical Genetics.

[31]  H. Hollema,et al.  Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. , 2001, Gastroenterology.

[32]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[33]  R. Kolodner,et al.  Identification of mismatch repair genes and their role in the development of cancer. , 1995, Current opinion in genetics & development.

[34]  Ronald A. DePinho,et al.  Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation , 2002, Nature.

[35]  Hiroyuki Miyoshi,et al.  Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. , 2002, Cancer research.

[36]  Daniel St Johnston,et al.  A role for Drosophila LKB1 in anterior–posterior axis formation and epithelial polarity , 2003, Nature.

[37]  R. Kolodner,et al.  Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Boland,et al.  Progress in genetic testing, classification, and identification of Lynch syndrome. , 2005, JAMA.

[39]  Bert Vogelstein,et al.  Hypermutability and mismatch repair deficiency in RER+ tumor cells , 1993, Cell.

[40]  Kathleen R. Cho,et al.  Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. , 2002, The Journal of biological chemistry.

[41]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[42]  Xin-Yuan Fu,et al.  Smad4 signalling in T cells is required for suppression of gastrointestinal cancer , 2006, Nature.

[43]  J. Gisbert,et al.  Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[44]  R. Kucherlapati,et al.  Tumor progression in Apc1638N mice with Exo1 and Fen1 deficiencies , 2007, Oncogene.

[45]  H. Ostrer,et al.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC , 1997, Nature Genetics.

[46]  J. Groden,et al.  Isoforms of the APC tumor suppressor and their ability to inhibit cell growth and tumorigenicity , 2004, Oncogene.

[47]  Lewis C Cantley,et al.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[49]  David Carling,et al.  Supplemental Data LKB 1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade , 2003 .

[50]  R. Kucherlapati,et al.  The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. , 2000, Cancer research.

[51]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[52]  M. Radman,et al.  Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer , 1995, Cell.

[53]  T. Prolla,et al.  Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over , 1996, Nature Genetics.

[54]  C. Cordon-Cardo,et al.  Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  L. Aaltonen,et al.  Mutations in the SMAD4/DPC4 gene in juvenile polyposis. , 1998, Science.

[56]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[57]  D. Schaid,et al.  Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. , 1998, Cancer research.

[58]  F. Kanai,et al.  LKB1 Associates with Brg1 and Is Necessary for Brg1-induced Growth Arrest* , 2001, The Journal of Biological Chemistry.

[59]  W. Bodmer,et al.  Clinical and molecular features of the hereditary mixed polyposis syndrome. , 1997, Gastroenterology.

[60]  K. Kinzler,et al.  Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.

[61]  K. Jishage,et al.  Role of Lkb1, the causative gene of Peutz–Jegher's syndrome, in embryogenesis and polyposis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R Fodde,et al.  A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Rustgi,et al.  The Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and Clinical Implications , 2003, Annals of Internal Medicine.

[64]  G. Palleschi,et al.  Molecular detection of microsatellite instability in basal cell carcinoma. , 2000, Oncology reports.

[65]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[66]  J. Potter,et al.  Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.

[67]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[68]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[69]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[70]  J. Qian,et al.  Caspase cleavage of the APC tumor suppressor and release of an amino-terminal domain is required for the transcription-independent function of APC in apoptosis , 2007, Oncogene.

[71]  O. Sieber,et al.  Myh Deficiency Enhances Intestinal Tumorigenesis in Multiple Intestinal Neoplasia (ApcMin/+) Mice , 2004, Cancer Research.

[72]  M. Taketo,et al.  Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/−p53−/− compound mutant mice , 2006, Oncogene.

[73]  V. McKusick,et al.  Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. , 1997, American journal of medical genetics.

[74]  M Oshima,et al.  Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[75]  R. Fishel,et al.  The Interaction of DNA Mismatch Repair Proteins with Human Exonuclease I* , 2001, The Journal of Biological Chemistry.

[76]  LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. , 2000 .

[77]  Peter K. Sorger,et al.  A role for the Adenomatous Polyposis Coli protein in chromosome segregation , 2001, Nature Cell Biology.

[78]  Tsung-Teh Wu,et al.  Frequent CpG island methylation in serrated adenomas of the colorectum. , 2003, The American journal of pathology.

[79]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[80]  L. Lipton,et al.  Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. , 2003, The New England journal of medicine.

[81]  C. Amos,et al.  Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p. , 1997, Cancer research.

[82]  H. Clevers,et al.  Mutations in the APC tumour suppressor gene cause chromosomal instability , 2001, Nature Cell Biology.

[83]  Asad Umar,et al.  Meiotic Pachytene Arrest in MLH1-Deficient Mice , 1996, Cell.

[84]  C. Moutou,et al.  Strategies and outcomes of PGD of familial adenomatous polyposis. , 2007, Molecular human reproduction.

[85]  R. Kucherlapati,et al.  Somatic Apc mutations are selected upon their capacity to inactivate the β‐catenin downregulating activity , 2000, Genes, chromosomes & cancer.

[86]  M. Seldin,et al.  Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. , 2002, Cancer research.

[87]  L. Cantley,et al.  The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. , 2001, Molecular cell.

[88]  Jian Yu,et al.  Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis , 1995, Cell.

[89]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[90]  W. Bodmer,et al.  Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. , 1996, American journal of human genetics.

[91]  T. Mäkelä,et al.  Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[92]  P. Tran,et al.  Interactions of Exo1p with components of MutLα in Saccharomyces cerevisiae , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[93]  P. Ross-Macdonald,et al.  Mutation of a meiosis-specific MutS homolog decreases crossing over but not mismatch correction , 1994, Cell.

[94]  T. Mäkelä,et al.  Growth suppression by Lkb 1 is mediated by a G 1 cell cycle arrest , 1999 .

[95]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[96]  Hans Clevers,et al.  De Novo Crypt Formation and Juvenile Polyposis on BMP Inhibition in Mouse Intestine , 2004, Science.

[97]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[98]  Darryl Shibata,et al.  Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DMA mismatch repair , 1998, Nature Genetics.

[99]  M. Bisgaard,et al.  Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rate , 1994, Human mutation.

[100]  D. Chung,et al.  The serrated polyp comes of age. , 2006, Gastroenterology.

[101]  S. Narumiya,et al.  Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice , 2001, Nature Medicine.

[102]  P. Fisher,et al.  Cell cycle arrest. , 1995, Science.

[103]  田中 宏史.  BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer , 2007 .

[104]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[105]  J. Tytell,et al.  Germ-line msh6 mutations in colorectal cancer families. , 1999, Cancer research.

[106]  Asad Umar,et al.  Requirement for PCNA in DNA Mismatch Repair at a Step Preceding DNA Resynthesis , 1996, Cell.

[107]  Tony Pawson,et al.  β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.

[108]  D. Chung,et al.  Correlation of polyp number and family history of colon cancer with germline MYH mutations. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[109]  H T Lynch,et al.  Hereditary colorectal cancer. , 1991, Seminars in oncology.

[110]  Ewout W Steyerberg,et al.  Prediction of MLH1 and MSH2 mutations in Lynch syndrome. , 2006, JAMA.

[111]  P. McCrea,et al.  Catenins as mediators of the cytoplasmic functions of cadherins , 1993, Journal of Cell Science.

[112]  M. Skolnick,et al.  Characteristics of familial colon cancer in a large population data base , 1989, Cancer.

[113]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.